HEALIX

BPC-157 250 mcg/mL • TB-500 250 mcg/mL

REGEN-2™ is a concentrated topical research matrix combining BPC-157 and TB-500 at an equal 1:1 ratio. The formulation was developed for laboratory investigation of peptide stability, localized delivery, cellular migration, angiogenic signaling, extracellular-matrix activity, and tissue-response pathways.

Research Areas of Interest

Cellular migration and tissue-response signaling

Fibroblast and extracellular-matrix activity

Angiogenesis-associated pathways

Actin organization and cellular motility

Nitric-oxide-associated signaling

Inflammatory-response mechanisms

Peptide stability and diffusion within a topical gel matrix

Research Components

BPC-157 — 250 mcg/mL

A synthetic 15-amino-acid peptide investigated primarily in preclinical models involving cytoprotection, vascular signaling, cellular migration, and connective-tissue response pathways.

TB-500 — 250 mcg/mL

A synthetic peptide associated with thymosin beta-4 research and investigated for its relationship to actin regulation, cellular motility, angiogenic activity, and tissue-response mechanisms.

Product Specifications

Form: Topical research gel

Net volume: 50 mL

BPC-157 concentration: 250 mcg/mL

TB-500 concentration: 250 mcg/mL

Total BPC-157: 12.5 mg

Total TB-500: 12.5 mg

Total peptide content: 25 mg

Peptide ratio: 1:1

Storage: Store tightly closed at 2–8°C and protect from direct light. Do not freeze. Topical bioavailability and long-term stability of the combined finished formulation have not been clinically established.

Research Use Only: Intended exclusively for laboratory, analytical, and formulation research. Not for human or veterinary use. Not intended for consumption, clinical application, diagnosis, treatment, cure, or prevention of disease. Keep out of reach of children.